ST. LUKE'S REGIONAL MEDICAL CENTER
| Site name: | St. Luke's Regional Medical Center | Active Prostate Cancer Clinical Trials: | |
| Contact: | Donald B. Wender, MD, PhD | That match your search: | No search performed |
| Phone: | 712-252-0088 | ||
| Site email: | Not Provided |
5
Active Prostate Cancer Clinical Trials at St. Luke's Regional Medical Center:
| TRIAL ID | TITLE | TRIAL PHASE |
|---|---|---|
| NCT00309985 | CHAARTED: ChemoHormonal Therapy Versus Androgen Ablation Randomized Trial for Extensive Disease in Prostate Cancer [CHAARTED] | Phase 3 |
| NCT00567580 | A Phase III Trial of Short Term Androgen Deprivation With Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients With a Rising PSA After Radical Prostatectomy | Phase 3 |
| NCT00079001 | A Randomized Double-Blind, Placebo-Controlled Phase III Study of Early Versus Standard Zoledronic Acid to Prevent Skeletal Related Events in Men With Prostate Cancer Metastatic to Bone | Phase 3 |
| NCT01238172 | The Men's Eating and Living (MEAL) Study: A Randomized Trial of Diet to Alter Disease Progression in Prostate Cancer Patients on Active Surveillance | Phase 3 |
| NCT01251861 | Phase II, Randomized Study of MK-2206 - Bicalutamide Combination in Patients With Rising PSA at High-Risk of Progression After Primary Therapy | Phase 2 |